Lantern Pharma Inc. – Trademark Portfolio
Entity Type: 03
Lantern Pharma Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 6 are pending. Notable registered marks include RADR, R RADR, and LANTERN PHARMA. The owner is based in Dallas, TX.
1920 McKinney Avenue
Dallas, TX 75201
Showing of trademarks Trademarks
Trademark Classifications
Lantern Pharma Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Lantern Pharma Inc. have?
Lantern Pharma Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 pending, 1 abandoned.
What trademark classes does Lantern Pharma Inc. file in?
Lantern Pharma Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Lantern Pharma Inc.'s most well-known trademarks?
Lantern Pharma Inc.'s registered trademark portfolio includes well-known marks such as RADR, R RADR, and LANTERN PHARMA. These are among 4 currently registered trademarks in the portfolio.
What is Lantern Pharma Inc.'s trademark registration success rate?
Lantern Pharma Inc. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 6 applications are pending review.